Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.
about
RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's diseaseObesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia.Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's diseaseSynaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's diseaseAssociation between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.BACE2 expression increases in human neurodegenerative disease.Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseDown syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brainPittsburgh compound B and the postmortem diagnosis of Alzheimer disease.Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.Nucleic acid oxidation: an early feature of Alzheimer's disease.Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.A Novel Small Molecule Modulator of Amyloid Pathology.APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.
P2860
Q34031631-E6C68565-A158-4C7D-B007-CDFAF023DAB6Q34500210-139985EC-E175-49F6-ACF7-16AE79C916E6Q35182808-1BE77177-46E6-42D9-A927-EC5D0EA97C1BQ35359220-4CD72D72-8F05-4C8A-AECA-62E8BC38DD42Q35677159-17C72614-E1C6-45A3-9111-13F4548395C7Q35917682-C7D0B635-F93E-4830-A515-B2063A6227D3Q36044265-C14F07EE-3D6D-4C66-BEF4-2585A4E7B32BQ36150463-A649CECF-5A86-44A5-86B7-09142ED57BF3Q36323138-8AA314EE-E5AB-49F1-BFBF-BA5865FF9B80Q36375559-576AEB9C-7E7C-446B-A33E-EB9C254F155EQ36713678-F0732FD4-A261-49CE-9A7E-EF173E4284D5Q37626224-3DC48E28-5ED0-418E-BE0A-F779D6FE45A0Q38609997-2319EA74-60A4-4086-96B5-595D1E49E165Q39779155-3D502A4D-0991-42E1-ABC1-53F8407825CCQ42534464-ADE262B7-6E11-4916-B8BE-17BEB4EE7C6CQ43796039-558D0F0E-43A4-4149-B514-30B245C0F022Q46847955-30C67E14-4FBB-4111-8708-DC3DBEA31C2C
P2860
Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@ast
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@en
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@nl
type
label
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@ast
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@en
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@nl
prefLabel
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@ast
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@en
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@nl
P2093
P2860
P1476
Effects of nonsteroidal anti-i ...... logy in mouse skeletal muscle.
@en
P2093
Adam M Weidner
Christa M Studzinski
Christopher J Holler
Dana M Niedowicz
Harry LeVine
M Paul Murphy
Rachel R Ahmed
Robin L Webb
Tina L Beckett
P2860
P304
P356
10.1016/J.NBD.2010.05.018
P577
2010-05-20T00:00:00Z